1. Home
  2. ABSI vs SPOK Comparison

ABSI vs SPOK Comparison

Compare ABSI & SPOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABSI
  • SPOK
  • Stock Information
  • Founded
  • ABSI 2011
  • SPOK 2004
  • Country
  • ABSI United States
  • SPOK United States
  • Employees
  • ABSI N/A
  • SPOK N/A
  • Industry
  • ABSI Biotechnology: Pharmaceutical Preparations
  • SPOK Telecommunications Equipment
  • Sector
  • ABSI Health Care
  • SPOK Telecommunications
  • Exchange
  • ABSI Nasdaq
  • SPOK Nasdaq
  • Market Cap
  • ABSI 353.8M
  • SPOK 318.9M
  • IPO Year
  • ABSI 2021
  • SPOK 1992
  • Fundamental
  • Price
  • ABSI $2.80
  • SPOK $16.54
  • Analyst Decision
  • ABSI Strong Buy
  • SPOK Hold
  • Analyst Count
  • ABSI 5
  • SPOK 1
  • Target Price
  • ABSI $8.40
  • SPOK $15.00
  • AVG Volume (30 Days)
  • ABSI 2.5M
  • SPOK 180.4K
  • Earning Date
  • ABSI 05-13-2025
  • SPOK 04-30-2025
  • Dividend Yield
  • ABSI N/A
  • SPOK 7.54%
  • EPS Growth
  • ABSI N/A
  • SPOK N/A
  • EPS
  • ABSI N/A
  • SPOK 0.77
  • Revenue
  • ABSI $4,534,000.00
  • SPOK $139,038,000.00
  • Revenue This Year
  • ABSI $158.58
  • SPOK $2.26
  • Revenue Next Year
  • ABSI $93.12
  • SPOK $0.14
  • P/E Ratio
  • ABSI N/A
  • SPOK $21.51
  • Revenue Growth
  • ABSI N/A
  • SPOK N/A
  • 52 Week Low
  • ABSI $2.01
  • SPOK $13.55
  • 52 Week High
  • ABSI $6.33
  • SPOK $17.96
  • Technical
  • Relative Strength Index (RSI)
  • ABSI 44.49
  • SPOK 59.93
  • Support Level
  • ABSI $2.85
  • SPOK $13.55
  • Resistance Level
  • ABSI $3.16
  • SPOK $16.60
  • Average True Range (ATR)
  • ABSI 0.20
  • SPOK 0.61
  • MACD
  • ABSI -0.03
  • SPOK 0.21
  • Stochastic Oscillator
  • ABSI 19.57
  • SPOK 95.22

About ABSI Absci Corporation

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

About SPOK Spok Holdings Inc.

Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.

Share on Social Networks: